Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
3/27/2026
Recent Executive Moves
3/27/2026
SK Biopharma Launches Epilepsy Drug Cenobamate in China
3/27/2026
GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...
3/27/2026
Jiangsu Aidea Targets Hong Kong IPO to Accelerate Global Expansion in ...
3/27/2026
China Pharma Market Set for Structural Shift as Innovation and Cost Pr...
3/27/2026
Insilico and Tenacia Expand AI-Driven Collaboration in CNS Drug Disco...
3/27/2026
CStone Reports Promising Clinical Progress for Trispecific Antibody CS...
3/27/2026
Pinnacle Medicines Secures $89M Series B to Advance Oral Peptide Pipel...
3/26/2026
Kelun-Biotech Secures IND Approval for SKB-103 in Advanced Solid Tumor...
3/26/2026
China Issues New Guidelines to Standardize Pharmaceutical Logistics Na...
3/26/2026
CSPC Reports Promising Phase 1 Data for B7-H3 ADC SYS6043 in Nasophary...
3/26/2026
Novo Nordisk 'Triple-G' Diabetes Candidate Advances to Phase 3 in Chin...
3/25/2026
Innovent Eyes China Approval as IBI302 Matches Eylea in Phase 3 nAMD S...
3/25/2026
China Seeks Public Input on Accelerating National Drug Traceability Sy...
3/25/2026
China Suspends Imports of Select Indian APIs Over GMP Violations
3/25/2026
BrightGene Reports Positive Phase 1 Data for Oral GLP-1/GIP Weight-Los...
3/25/2026
Castalysis Secures Pre-A Funding to Advance alphaCas Gene Editing Plat...
3/25/2026
Cellgenes Raises CNY 100M+ Pre-C to Advance Stem Cell Therapy Pipeline
3/25/2026
Insilico Launches PandaClaw to Streamline AI-Driven Drug Discovery
3/25/2026
Gilead Nears $2B Ouro Deal Anchored by China-Origin BCMA/CD3 Asset
3/25/2026
Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD
3/25/2026
Hope Medicine Advances HMI-115 Into Phase III for Endometriosis
3/24/2026
LG Chem's Tigulixostat Advances to Phase 3 in China Through Innovent P...
3/24/2026
Sanofi Opens Chengdu Innovation Hub to Strengthen China Operations
3/24/2026
Chinese Commerce Minister Meets PhRMA, MNC Executives to Discuss Indus...
3/24/2026
RemeGen's Disitamab Vedotin Approved in China for HER2-Low Breast Canc...
3/24/2026
Kali Therapeutics Licenses Tri-Specific TCE KT501 to Sanofi in Global ...
3/24/2026
WuXi AppTec Leans Further on US Market as Other Revenues Weaken
3/24/2026
Novartis Commits $480M to Expand China Footprint
3/23/2026
Mabgalaxy Raises Near CNY 100M Angel Round to Advance AI-Driven Antibo...
Page:
1
/
61
Total number of articles:
1810
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit